renal cell carcinoma kidney cancer
Conditions
Interventions
N.v.t.
Sponsors
Stichting PRO-RCC
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: • Histologically proven RCC or mRCC or high clinical suspicion • Age >= 18 years at time of inclusion • Written informed consent • Able to read and understand the patient information
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This efficient and unique infrastructure for RCC research creates a facility, that will yield detailed insights in RCC disease aspects and treatment in the Netherlands and enable improved patient accrual in clinical trials. Ultimately, this will lead to an introduction of improved new treatment options in daily clinical practice. Furthermore, the collected data on HRQoL, symptoms and clinical management from diagnosis to death will result in robust *real-world* patient data. Data from patients who undergo registered and experimental therapies can be studied to answer relevant questions on relapse and progression to invasive or metastatic disease, and on optimal (sequencing of) treatment regimens and HRQoL as part of the decision making. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nv.t. | — |
Countries
Netherlands
Contacts
Public ContactA.D. Bins
Stichting PRO-RCC
Outcome results
None listed